Results 101 to 110 of about 2,560 (200)

GSH‐Depleted Platinum(II) Metallacycles to Turn On the NIR Emission in Boosting Synergistic Cancer Therapy

open access: yesAggregate
Agents to combine functions simultaneously are highly needed but still challenging in synergistic therapy. Particularly, capabilities to deplete glutathione (GSH) in tumors and monitor their process are also important.
Qifei Shen   +12 more
doaj   +1 more source

Near-infrared photoimmunotherapy for recurrent cancer at the base of the tongue [PDF]

open access: yes
Near-infrared photoimmunotherapy (NIR-PIT) is a novel therapeutic approach that targets epidermal growth factor receptor (EGFR). In NIR-PIT, administration of cetuximab sarotalocan sodium is followed by laser irradiation of the affected area, which ...
Nishikori, Asami   +6 more
core   +1 more source

Dual‐Activatable Nano‐Immunomodulator for NIR‐II Fluorescence Imaging‐Guided Precision Cancer Photodynamic Immunotherapy

open access: yesAdvanced Science
Photodynamic immunotherapy which combines photodynamic therapy with immunotherapy has become an important and effective method for the treatment of cancer.
Shanchao Diao   +11 more
doaj   +1 more source

Enzyme-Integrated Semiconducting Polymer Nanoplatform Remodels Physical and Metabolic Tumor Barriers for Potentiated Second Near-Infrared Region Photoimmunotherapy

open access: yes
Tumor microenvironment (TME)-associated physical and metabolic barriers severely limit the therapeutic efficacy of cancer nanomedicine. Dense extracellular matrix (ECM) impedes nanoparticle penetration, while lactate accumulation induces ...
Guoguo Ye   +6 more
core   +1 more source

An Overview of Target Membrane Proteins for Near-Infrared Photoimmunotherapy

open access: yes
Near-infrared photoimmunotherapy (NIR-PIT) is a recently developed cancer treatment that utilizes antibody–photoabsorber (IRDye700DX [IR700]) conjugates and NIR light.
Motofumi Suzuki, Hirofumi Hanaoka
core   +1 more source

Phototherapy Strategies for Cancer Treatment: Mechanisms and Emerging Nanomaterials

open access: yesAggregate
Phototherapy has become a significant research direction in tumor therapy owing to its high spatial selectivity, low systemic toxicity, and excellent biocompatibility. In recent years, diverse strategies including photodynamic therapy (PDT), photothermal
Fan Liu, Jun Huang
doaj   +1 more source

Comparative Analysis of Clinical Outcomes and Financial Aspects of Phototherapies and Immunotherapy for Cancer

open access: yesAdvanced Science
Photo‐responsive/activable nanomedicine‐driven therapies have emerged as a transformative approach to effectively target and eliminate tumors across different types of solid cancers.
Deepak S. Chauhan   +6 more
doaj   +1 more source

Real-Time Fluorescence Monitoring System for Optimal Light Dosage in Cancer Photoimmunotherapy

open access: yesPharmaceuticals
Background/Objectives: Near-infrared photoimmunotherapy (NIR-PIT) was recently approved for the treatment of unresectable locally advanced or recurrent head and neck cancers in Japan; however, only one clinical dose has been validated in clinical trials,
Hideki Tanaka   +12 more
doaj   +1 more source

Mitochondrial-Targeting Nanotrapper Captured Copper Ions to Alleviate Tumor Hypoxia for Amplified Photoimmunotherapy in Breast Cancer

open access: yes
Hypoxia is a pervasive feature of solid tumors, which significantly limits the therapeutic effect of photodynamic therapy (PDT) and further influences the immunotherapy efficiency in breast cancer.
Shengjie Sun (679497)   +9 more
core   +1 more source

Near-Infrared Photoimmunotherapy Targeting Prostate Cancer with Prostate-Specific Membrane Antigen (PSMA) Antibody

open access: yes, 2017
Prostate-specific membrane antigen (PSMA) is a membrane protein that is overexpressed manifold in prostate cancer and provides an attractive target for molecular therapy.
Tadanobu Nagaya   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy